Green Molecular, a spin-out of the University of Valencia, licences its pharma tech to cosmetics firm ChromaDex.

US-based ChromaDex has announced a licensing agreement with biotech Green Molecular, a spin-out of Spain’s University of Valencia.

The natural products firm is building a portfolio of patents relating to pterostilbene, a product used in skincare and developed by Green Molecular. It is the eighth patent ChromaDex has acquired for pterostilbene, and the second for the related product pTeroPure, having signed a similar deal with the University of California, Irvine in 2011.

Frank Jaksch, chief executive of ChromaDex, said: “We…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?